Postmortem neuropathological examination of brain tissue is considered the gold standard for understanding many neurological diseases, including Alzheimer’s disease and related dementias (ADRD). Although fluid and imaging biomarkers provide scientists and clinicians with valuable insights into the diseases of the brain, these measures are standardized with brain autopsy to give researchers direct evidence needed to confirm diagnoses, study disease processes, and develop future treatments. N...
